On June 10, Anlan Medical (China) Co., Ltd. invested and established by Wanbond Group in South Africa officially acquired two well-known medical device companies in South Africa, Tmike and Ailit, at the Gallagher Exhibition in Johannesburg, South Africa, and held an exhibition. The official handover ceremony and press conference. The total transaction value of the acquisition is 264 million rand, equivalent to more than 120 million yuan. Yu Yong, Counselor of the Chinese Embassy in South Africa, Zhao Shouming, Chairman, Gao Jian, Co-Chairman of Anlan Securities, John Otto, General Manager of South Africa's Elliot, William Skyes, General Manager of Temac and the South African medical industry Colleagues attended the handover ceremony and press conference.
 
The two medical device companies in this acquisition are international companies facing the world. Among them, Erlit is a manufacturer of implantable artificial orthopaedic products with strong research and development capabilities. Its products can be compared with multinational companies such as Johnson & Johnson and Medtronic. Athletics. Techmac is one of the enterprises with "turnkey" engineering capabilities in medical equipment sales, medical engineering services and overall hospital design, from the procurement, installation, and maintenance of a full set of equipment, to the development of hospital management systems and technical training for doctors.
 
According to the strategic thinking of Wanbangde Group's "big health industry" globalization layout, the group has started to enter the medical device industry since last year. This time, through the acquisition of the equity of Tekek and Ailite and the investment in follow-up projects, the adjustment of the industrial structure will be accelerated, and the transformation and upgrading of the company will be promoted. Zhao Shouming, chairman of the group, said that this acquisition is the beginning of Wanbangde Group's investment in the big health industry in Africa. This acquisition not only makes up for the company's shortcomings in research and development, but also uses South Africa as a bridgehead to make good use of China's manufacturing capabilities and Capital strength, export more medicines and medical device products to underserved Africa.
 
In order to industrialize the technologies of Ailit and Temac, Wanbonde Group also acquired two domestic companies specializing in the production of medical devices. Zhao Shouming, chairman of the group, said that building an orthopedic device production base in Asia is one of the goals of Wanbangde Group in the future. Give full play to the advantages of pharmaceutical and medical device research and development, keep pace with the pharmaceutical industry, and vigorously develop international and domestic markets.
 
The success of Wanbond Group's acquisition of two well-known medical companies in South Africa signifies that Wanbonde Group is stepping out in a steady pace, facing the world, and officially entering the ranks of multinational group companies. , to start the Group's big health industry development strategy.

Chairman Zhao Shouming acquired South Africa's Tekek and Ailit